Associated Papers
Tumor-derived CK1α mutations enhance MDMX inhibition of p53.
Liu X et al.
Oncogene, 2020
Impact of chromosome alterations, genetic mutations and clonal hematopoiesis of indeterminate potential (CHIP) on the classification and risk stratification of MDS.
Ganguly BB et al.
Blood Cells, Molecules & Diseases, 2018
The molecular pathogenesis of the myelodysplastic syndromes.
Pellagatti A et al.
European Journal of Haematology, 2015
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.
Schneider RK et al.
Cancer Cell, 2014
Select a paper to view details